Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.430
-0.080 (-5.30%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Zentalis Pharmaceuticals Employees
Zentalis Pharmaceuticals had 166 employees as of December 31, 2024. The number of employees decreased by 2 or -1.19% compared to the previous year.
Employees
166
Change (1Y)
-2
Growth (1Y)
-1.19%
Revenue / Employee
$406,175
Profits / Employee
-$999,030
Market Cap
102.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ZNTL News
- 4 days ago - Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting - GlobeNewsWire
- 26 days ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates - GlobeNewsWire
- 4 weeks ago - Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025 - GlobeNewsWire
- 6 weeks ago - Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer - GlobeNewsWire
- 7 weeks ago - Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer - GlobeNewsWire
- 2 months ago - Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire